MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Public ClinicalTrials.gov record NCT00048061. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Double Dummy, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of Monthly Oral Administration of 100 mg and 150 mg Ibandronate With 2.5 mg Daily Oral Ibandronate in Postmenopausal Osteoporosis
Study identification
- NCT ID
- NCT00048061
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 1,609 participants
Conditions and interventions
Conditions
Interventions
- Calcium Dietary Supplement
- Ibandronate [Bonviva/Boniva] Drug
- Vitamin D Dietary Supplement
Dietary Supplement · Drug
Eligibility (public fields only)
- Age range
- 55 Years to 80 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2002
- Primary completion
- Nov 30, 2004
- Completion
- Nov 30, 2004
- Last update posted
- Mar 28, 2018
2002 – 2004
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Irvine | California | 92618 | — |
| Not listed | Loma Linda | California | 92357 | — |
| Not listed | Los Angeles | California | 90211 | — |
| Not listed | Oakland | California | 94612 | — |
| Not listed | Rancho Mirage | California | 92270 | — |
| Not listed | Lakewood | Colorado | 80227 | — |
| Not listed | Gainesville | Florida | 32607 | — |
| Not listed | Bethesda | Maryland | 20817 | — |
| Not listed | Wheaton | Maryland | 20902 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Billings | Montana | 59120 | — |
| Not listed | Omaha | Nebraska | 68131 | — |
| Not listed | Livingston | New Jersey | 07039 | — |
| Not listed | Albuquerque | New Mexico | 87106 | — |
| Not listed | Portland | Oregon | 97213 | — |
| Not listed | Wyomissing | Pennsylvania | 19610 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Richmond | Virginia | 23294 | — |
| Not listed | Seattle | Washington | 98144 | — |
| Not listed | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00048061, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2018 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00048061 live on ClinicalTrials.gov.